Interleukin-31: A Pro-inflammatory Oriented Cytokine
Type 2 immunity is represented by T helper 2 (Th2) lymphocytes and the cytokines produced downstream (Interleukin (IL)-4, IL-13, IL-31). They are increasingly recognized as pivotal mediators in the pathogenesis of immune-mediated dermatological conditions such as atopic dermatitis (AD) and psoriasis...
Saved in:
| Main Authors: | Giuseppe Murdaca, Francesca Paladin, Andrea Orsi, Sebastiano Gangemi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-06-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/30/6/10.31083/FBL37462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative short-term efficacy of Janus kinase 1 inhibitors and anti-interleukin-13 antibodies in atopic dermatitis: a retrospective cohort analysis based on real-world data
by: Emi Sato, et al.
Published: (2025-08-01) -
Alarmins in Chronic Spontaneous Urticaria: Immunological Insights and Therapeutic Perspectives
by: Angela Rizzi, et al.
Published: (2024-12-01) -
PROPORTION OF NAIVE CD45RA+ AND CD31+T-CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS UNDER STIMULATION WITH HOMEOSTATIC FACTORS IN VITRO
by: E. A. Blinova, et al.
Published: (2021-10-01) -
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion
by: Madelene Lindkvist, et al.
Published: (2025-05-01) -
Emerging Therapies in the Treatment of Prurigo Nodularis: Biological Therapy and Systematic Review of Literature
by: Gaetano Licata, et al.
Published: (2025-05-01)